Report overview
This report contains market size and forecasts of Haemato Oncology Testing in Global, including the following market information:
Global Haemato Oncology Testing Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Haemato Oncology Testing market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Leukaemia Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Haemato Oncology Testing include Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, Haplox, Amoy Dx, Genosaber and YZY Biopharma and etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Haemato Oncology Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Haemato Oncology Testing Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Haemato Oncology Testing Market Segment Percentages, by Type, 2022 (%)
Leukaemia
Lymphoma
Hodgkin Lymphoma
Others
Global Haemato Oncology Testing Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Haemato Oncology Testing Market Segment Percentages, by Application, 2022 (%)
Clinical Laboratories
Hospitals
Academic and Research Institutes
Others
Global Haemato Oncology Testing Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Haemato Oncology Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Haemato Oncology Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Haemato Oncology Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Berry Genomics
Burning Rock Dx
BGI
Genetron
Haplox
Amoy Dx
Genosaber
YZY Biopharma
Wondfo
